Literature DB >> 28775481

PLASMID MEDIATED DRUG RESISTANCE IN VIBRIO CHOLERAE 0139 BENGAL.

R N Misra1, N K Debata2, A Nagend1, T S Hyder3, V C Ohri4.   

Abstract

Sixteen strains of Vibrio cholerae were isolated from cases of diarrhoea. Out of these, 12 (75%) were identified as Vibrio cholerae 0139 synonym Bengal and 4 (25%) as Vibrio cholerae El Tor by standard biochemical and serological tests. Modified CAMP reaction in sheep blood agar showed that 0139 produced moderate hemolysis, El Tor produced wider zone of hemolysis whereas Classical Vibrio cholerae produced no zone of hemolysis (CAMP negative). Break point minimum inhibitory concentration (MIC) by agar dilution method showed that all 0139 strains were resistant to ampicillin 8 mg/L, streptomycin 1 mg/L, chloramphenicol 8 mg/L, sulphamethoxazole 32 mg/L and trimethoprim 0.3-128 mg/L, 58.3% were sensitive to gentamicin 1 mg/L, and all were sensitive to norfloxacin 1 mg/L and cefotaxime 1 mg/L. Resistance to trimethoprim, sulphamethoxazole, ampicillin and gentamicin in 5 strains could be transferred to E coli K-12 by conjugation experiment at a rate of 5×10-6 to 4×10-3. Distinct plasmid bands of 35.8 mega daltons could be seen in agarose gel electrophoresis.

Entities:  

Keywords:  CAMP test; Drug resistance; Plasmid; Vibrio cholerae 0139.

Year:  2017        PMID: 28775481      PMCID: PMC5531623          DOI: 10.1016/S0377-1237(17)30548-8

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  13 in total

1.  A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy.

Authors: 
Journal:  J Antimicrob Chemother       Date:  1991-06       Impact factor: 5.790

2.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

Review 3.  [Epidemiological, clinical, and microbiological characteristics of the new strain Vibrio cholerae 0139].

Authors:  B Ivanoff; J Clemens
Journal:  Med Trop (Mars)       Date:  1994

Review 4.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 5.  Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype.

Authors:  M K Waldor; J J Mekalanos
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

6.  Adherence to human small intestines of capsulated Vibrio cholerae O139.

Authors:  T Yamamoto; M J Albert; R B Sack
Journal:  FEMS Microbiol Lett       Date:  1994-06-01       Impact factor: 2.742

7.  Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.

Authors:  J G Morris; G E Losonsky; J A Johnson; C O Tacket; J P Nataro; P Panigrahi; M M Levin
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

8.  The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.

Authors:  M K Waldor; R Colwell; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

9.  Characterization of Vibrio cholerae O139 synonym Bengal isolated from patients with cholera-like disease in Bangladesh.

Authors:  N Higa; Y Honma; M J Albert; M Iwanaga
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

10.  Development and evaluation of rapid monoclonal antibody-based coagglutination test for direct detection of Vibrio cholerae O139 synonym Bengal in stool samples.

Authors:  F Qadri; A Chowdhury; J Hossain; K Chowdhury; T Azim; T Shimada; K M Islam; R B Sack; M J Albert
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.